Improving safety in autologous HSCT for systemic sclerosis.
Department of Haematology, Sheffield Teaching Hospitals National Health Service Foundation Trust and University of Sheffield, Royal Hallamshire Hospital, Sheffield S10 2JF, UK. john.snowden@sth.nhs.uk
John A
JA
Snowden
Mohammed
M
Akil
David G
DG
Kiely
D002423:Cause of Death; D005260:Female; D006333:Heart Failure / Q000401:mortality*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods* / Q000401:mortality*; D006801:Humans; D008297:Male; D010494:Pericarditis, Constrictive / Q000401:mortality*; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods* / Q000401:mortality*; D045743:Scleroderma, Diffuse / Q000401:mortality* / Q000628:therapy*; D045745:Scleroderma, Limited / Q000401:mortality* / Q000628:therapy*; D018805:Sepsis / Q000401:mortality*; D019172:Transplantation Conditioning